Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter LIV-1 (Ladiratuzumab Biosimilar) Antikörper

Research Grade Reaktivität: Human ELISA Wirt: Humanized Monoclonal unconjugated Recombinant Antibody
Produktnummer ABIN7490985
  • Target
    LIV-1 (Ladiratuzumab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    Humanized
    Klonalität
    Monoklonal
    Applikation
    ELISA
    Verwendungszweck
    Anti-LIV-1 (ladiratuzumab biosimilar) mAb
    Produktmerkmale
    hLIV22
    Aufreinigung
    Purified from cell culture supernatant by affinity chromatography
    Güteklasse
    Research Grade
    Isotyp
    IgG1
  • Applikationshinweise
    ELISA 1:5000-10000
    Kommentare

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute with deionized water
    Buffer
    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Haltbarkeit
    12 months
  • Target
    LIV-1 (Ladiratuzumab Biosimilar)
    Substanzklasse
    Biosimilar
    Hintergrund
    Synonyms: LIV1, SLC39A6, ZIP-6
    UniProt
    Q13433
Sie sind hier:
Kundenservice